Clinical Trial

Home Blood Pressure Variability and Its Link to Arteriosclerosis and Metabolic Dysfunction in Hypertensive Patients

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 1, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
This observational study investigates the correlation between home blood pressure variability (BPV) and arteriosclerosis, alongside metabolic indicators, in hypertensive patients over a three-year period. The research specifically focuses on the predictive value of home BPV for major adverse cardiovascular events (MACE) including myocardial infarction, stroke, and heart failure hospitalizations. Utilizing a mobile application called Healthscan for daily BP monitoring, the study aims to enhance the understanding of how BPV impacts cardiovascular and metabolic health in a real-world setting.
Trial Details
NCT Number NCT06394934
Lead Sponsor Korea University Anam Hospital
Collaborators: Korean Society of Hypertension
Conditions Hypertension, Blood Pressure Monitoring, Home, Arteriosclerosis, Metabolic Syndrome X
Enrollment 4,188 participants
Start Date 2024-01-09
Primary Completion 2024-12-31 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-05-01